financetom
Business
financetom
/
Business
/
Mexico president welcomes billionaire's purchase of stake in local Citi retail unit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mexico president welcomes billionaire's purchase of stake in local Citi retail unit
Sep 25, 2025 9:39 AM

MEXICO CITY, Sept 25 (Reuters) -

Mexican

President Claudia Sheinbaum on Thursday said it was "good

news" that a local billionaire had tied up an agreement to

purchase a 25% stake in Citigroup's ( C/PN ) retail unit in the

country, Banamex.

Sheinbaum cheered the Citigroup ( C/PN ) deal putting Banamex "in the

hands of Mexicans" by selling the stake for $2.3 billion to

business magnate Fernando Chico Pardo, who chairs airport

operator ASUR.

Analysts saw the announcement as a positive step towards

Citigroup's ( C/PN ) full divestment. The price of the stake, valuing the

full Banamex at around $9.12 billion, effectively creates a

'floor' for a potential initial public offering (IPO). "At least

it gives clarity on how much a full divestiture could raise",

said Mike Mayo, Wells Fargo's bank analyst, in a phone

interview.

In a note published on Thursday, Mayo said a potential

Banamex IPO could be delayed to mid to late 2026, instead of the

formerly expected early 2026 timeframe.

Bank of America analyst Ebrahim Poonawala said the deal was

positive and a significant step towards reaching higher

profitability. Poonawala sees the deal as the replacement for a

first share sale in an IPO, as Citigroup ( C/PN ) had estimated to sell

15 to 20% in the first transaction. "In addition, the deal could

be viewed as setting a potential floor price for Banamex ahead

of an IPO," he said in a note published on Thursday.

The analyst added that Fernando Chico Pardo has a

longstanding relationship with Banamex. His wife, Veronica

Hernandez, is the sister of Roberto Hernandez, former owner and

CEO of Banamex.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Dalata Hotel Group plc
Form 8.3 - Dalata Hotel Group plc
Sep 15, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if...
DiamondLake Withdraws from Unicoin Transaction, Reaffirms Commitment to SEC Compliance and Tokenization Strategy
DiamondLake Withdraws from Unicoin Transaction, Reaffirms Commitment to SEC Compliance and Tokenization Strategy
Sep 15, 2025
SALT LAKE CITY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Diamond Lake Minerals, Inc. ( DLMI ) based upon our findings during due diligence DiamondLake is withdrawing from the Unicoin transaction and terminating the Memorandum of Understanding. DiamondLake has attempted in good faith to pursue the Share Exchange with Unicoin however it was simply not possible based upon our findings. Thus,...
GreenArrow Expands National Footprint with Acquisition of James D. Hinson Electrical
GreenArrow Expands National Footprint with Acquisition of James D. Hinson Electrical
Sep 15, 2025
JACKSONVILLE, Fla., Sept. 15, 2025 /PRNewswire/ -- GreenArrow is excited to announce its latest strategic partnership with the acquisition of James D. Hinson Electrical Contracting Co. (Hinson). This acquisition strengthens GreenArrow's position as a leading provider of transportation electrical infrastructure services, now serving four major regions of the United States. Based in Jacksonville, Florida, Hinson was founded in 1986 by...
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera’s Portfolio of Factor XIa Inhibitors
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera’s Portfolio of Factor XIa Inhibitors
Sep 15, 2025
Acquisition significantly enhances the Company’s pipeline by adding novel assets in acute and chronic anticoagulation settingsCompany is strategically poised to deliver differentiated therapeutics across the spectrum of cardiovascular thrombotic risk PONTE VEDRA, Fla., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. ( CVKD ) , a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today...
Copyright 2023-2026 - www.financetom.com All Rights Reserved